vs
CuriosityStream Inc.(CURI)与TRANSACT TECHNOLOGIES INC(TACT)财务数据对比。点击上方公司名可切换其他公司
CuriosityStream Inc.的季度营收约是TRANSACT TECHNOLOGIES INC的1.7倍($19.2M vs $11.5M),CuriosityStream Inc.同比增速更快(35.8% vs 11.9%),CuriosityStream Inc.自由现金流更多($3.9M vs $589.0K),过去两年CuriosityStream Inc.的营收复合增速更高(26.5% vs 3.5%)
CuriosityStream是来自美国的流媒体订阅点播服务商,主打纪实类影视内容,涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外,该公司还开设了Curiosity纪实线性电视频道,目前已接入FuboTV、Roku频道等多个平台。
该公司相关归属主体罗珀技术公司是一家控股集团,主要投资控股科技领域的各类企业,业务覆盖多个科技细分赛道,依托旗下子公司开展多元化科技业务布局。
CURI vs TACT — 直观对比
营收规模更大
CURI
是对方的1.7倍
$11.5M
营收增速更快
CURI
高出23.9%
11.9%
自由现金流更多
CURI
多$3.4M
$589.0K
两年增速更快
CURI
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $19.2M | $11.5M |
| 净利润 | $-3.8M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | -17.6% | -10.1% |
| 净利率 | -19.7% | — |
| 营收同比 | 35.8% | 11.9% |
| 净利润同比 | -34.6% | — |
| 每股收益(稀释后) | $-0.07 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CURI
TACT
| Q4 25 | $19.2M | $11.5M | ||
| Q3 25 | $18.4M | $13.2M | ||
| Q2 25 | $19.0M | $13.8M | ||
| Q1 25 | $15.1M | $13.1M | ||
| Q4 24 | $14.1M | $10.2M | ||
| Q3 24 | $12.6M | $10.9M | ||
| Q2 24 | $12.4M | $11.6M | ||
| Q1 24 | $12.0M | $10.7M |
净利润
CURI
TACT
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-3.7M | $15.0K | ||
| Q2 25 | $784.0K | $-143.0K | ||
| Q1 25 | $319.0K | $19.0K | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $-3.1M | $-551.0K | ||
| Q2 24 | $-2.0M | $-319.0K | ||
| Q1 24 | $-5.0M | $-1.0M |
毛利率
CURI
TACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率
CURI
TACT
| Q4 25 | -17.6% | -10.1% | ||
| Q3 25 | -24.5% | 0.1% | ||
| Q2 25 | 2.5% | -1.9% | ||
| Q1 25 | 0.5% | -0.1% | ||
| Q4 24 | -27.4% | -10.3% | ||
| Q3 24 | -25.8% | -7.7% | ||
| Q2 24 | -20.6% | -3.8% | ||
| Q1 24 | -30.4% | -12.2% |
净利率
CURI
TACT
| Q4 25 | -19.7% | — | ||
| Q3 25 | -20.4% | 0.1% | ||
| Q2 25 | 4.1% | -1.0% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | -19.9% | — | ||
| Q3 24 | -24.3% | -5.1% | ||
| Q2 24 | -16.4% | -2.8% | ||
| Q1 24 | -42.0% | -9.7% |
每股收益(稀释后)
CURI
TACT
| Q4 25 | $-0.07 | $-0.11 | ||
| Q3 25 | $-0.06 | $0.00 | ||
| Q2 25 | $0.01 | $-0.01 | ||
| Q1 25 | $0.01 | $0.00 | ||
| Q4 24 | $-0.05 | $-0.80 | ||
| Q3 24 | $-0.06 | $-0.06 | ||
| Q2 24 | $-0.04 | $-0.03 | ||
| Q1 24 | $-0.09 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $27.3M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $41.5M | $31.1M |
| 总资产 | $75.7M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CURI
TACT
| Q4 25 | $27.3M | $20.4M | ||
| Q3 25 | $27.8M | $20.0M | ||
| Q2 25 | $28.1M | $17.7M | ||
| Q1 25 | $33.4M | $14.2M | ||
| Q4 24 | $32.1M | $14.4M | ||
| Q3 24 | $33.2M | $11.3M | ||
| Q2 24 | $39.5M | $11.1M | ||
| Q1 24 | $38.8M | $10.6M |
股东权益
CURI
TACT
| Q4 25 | $41.5M | $31.1M | ||
| Q3 25 | $47.2M | $31.8M | ||
| Q2 25 | $49.8M | $31.3M | ||
| Q1 25 | $58.1M | $30.9M | ||
| Q4 24 | $57.8M | $30.6M | ||
| Q3 24 | $62.2M | $38.4M | ||
| Q2 24 | $64.8M | $38.5M | ||
| Q1 24 | $67.0M | $38.6M |
总资产
CURI
TACT
| Q4 25 | $75.7M | $44.8M | ||
| Q3 25 | $74.7M | $45.0M | ||
| Q2 25 | $78.7M | $44.5M | ||
| Q1 25 | $85.3M | $44.2M | ||
| Q4 24 | $86.2M | $44.0M | ||
| Q3 24 | $87.6M | $50.5M | ||
| Q2 24 | $90.9M | $50.4M | ||
| Q1 24 | $94.6M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $4.0M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $3.9M | $589.0K |
| 自由现金流率自由现金流/营收 | 20.5% | 5.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势,按日历期对齐
经营现金流
CURI
TACT
| Q4 25 | $4.0M | $609.0K | ||
| Q3 25 | $4.4M | $3.6M | ||
| Q2 25 | $2.8M | $3.6M | ||
| Q1 25 | $1.9M | $-161.0K | ||
| Q4 24 | $3.0M | $2.4M | ||
| Q3 24 | $2.3M | $327.0K | ||
| Q2 24 | $2.2M | $636.0K | ||
| Q1 24 | $666.0K | $-1.5M |
自由现金流
CURI
TACT
| Q4 25 | $3.9M | $589.0K | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | $1.8M | $-171.0K | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | — | $499.0K | ||
| Q1 24 | — | $-1.6M |
自由现金流率
CURI
TACT
| Q4 25 | 20.5% | 5.1% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | 12.2% | -1.3% | ||
| Q4 24 | — | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | -14.9% |
资本支出强度
CURI
TACT
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 1.2% | ||
| Q1 24 | 0.0% | 1.0% |
现金转化率
CURI
TACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图